Navigation Links
Varian, Inc. Reports First Quarter 2008 Results
Date:1/23/2008

VARIAN, INC. AND SUBSIDIARY COMPANIES

RECONCILIATION OF GAAP TO ADJUSTED RESULTS - ACTUAL

UNAUDITED RESULTS OF OPERATIONS

(In thousands, except margin data)

First Quarter FY 2008 and First Quarter FY 2007

Fiscal Quarter Ended

------------------------------

December 28, December 29,

2007 2006

------------ ------------

SCIENTIFIC INSTRUMENTS SEGMENT

------------------------------

Operating Earnings

U.S. GAAP as reported $19,802 $18,867

Adjustments:

Share-based compensation expense 846 1,030

Acquisition-related intangible

amortization 1,829 2,247

Acquisition-related inventory

write-up amortization 480 271

Restructuring and other related costs 2,001 115

------------ ------------

As adjusted $24,958 $22,530

============ ============

Operating Margins

U.S. GAAP as reported 10.1 % 10.7 %

Adjustments:

Share-based compensation expense 0.4 0.5

Acquisition-related intangible

amortization 1.0 1.2

Acquisition-related inventory

write-up amortization 0.2 0.2

Restructuring and other rel
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 The laboratory information management ... witnessed a number of technological advancements due to factors ... growing need to integrate healthcare systems, and increasing government ... in system integration. Key players in the market focus ...
(Date:1/22/2015)... WI (PRWEB) January 22, 2015 Dr. Greg ... the 12th annual Scripps Natural Supplements Pre-Conference seminar on probiotics ... Conference is an annual continuing education conference for health care ... and included the topic of probiotics in health. Dr. Leyer ...
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... , , , , ... -- 3SBio Inc.,(Nasdaq: SSRX ), a leading biotechnology ... primarily,in China, today announced that it has submitted its ... Food and Drug,Administration ("SFDA") for Feraheme (ferumoxytol) Injection for ...
... , , , ... and Technology Department has announced a $1.8 million grant ... the,research and development of human umbilical cord mesenchymal stem ... Co., Ltd. ( http://www.beikebiotech.com ), is working with,Jiangsu ...
... ... Selected To Develop A Social Media Strategy For The Massachusetts Biotechnology Council ... Boston, MA (PRWEB) ... AJ Gerritson, today announced that the Massachusetts Biotechnology Council’s (MassBio) has selected the Boston-based ...
Cached Biology Technology:3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 23SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 33SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM) 4Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials 2Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials 3Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials 4 The Massachusetts Biotechnology Council Selects Social Media Marketing Agency 451 Marketing To Develop A Social Media Strategy For 2010 2 The Massachusetts Biotechnology Council Selects Social Media Marketing Agency 451 Marketing To Develop A Social Media Strategy For 2010 3
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
(Date:1/22/2015)... MUNICH , January 22, 2015 ... its tenth year  The European Patent Office to present ... Two British nominations to be featured: Christofer Toumazou ... week featuring former finalists and winners of the Award   ...
(Date:1/22/2015)...   EyeLock, Inc. , a market leader of iris-based identity ... to the new role of Senior Vice President of ... of mobile platforms and wearable solutions for EyeLock,s technologies. Gerber ... the semiconductor industry to his role at EyeLock, with expertise ...
Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... Technologies, M2000, a pocket-sized rugged handheld that scans ... Embedded Handheld 6.5 operating system and a new ... capabilities. (Logo:   http://photos.prnewswire.com/prnh/20090408/LA96741LOGO ) ... specifically for enterprise handheld computers, which provide real-time ...
... Scientists at The Scripps Research Institute have devised ... used widely in the synthesis of drugs and other ... CF3 molecule to the original compound, often making it ... body longer. With the new technique, chemists can perform ...
... adapt to environmental challenges are likely influenced by variations ... the plant,s growth and the external environment, reports a ... The findings were revealed by a genomewide association ... common research plant. The researchers, led by UC Davis ...
Cached Biology News:DAP Technologies Adds Windows Embedded Handheld 6.5 and Biometrics Module to its M2000 Rugged Handheld 2Scientists find easier, cheaper way to make a sought-after chemical modification to drugs 2Genomewide mapping reveals developmental and environmental impacts 2
...
... to MKK6 (phospho S207) ( Abpromise ... Antigen: Synthetic phosphopeptide ... phosphorylation site of Serine 207 (V-D-S ... Gene ID: 5608 ...
...
Goat polyclonal to ORC2L ( Abpromise for all tested applications). entrezGeneID: 4999 SwissProtID: Q13416...
Biology Products: